Peak P (%) | PMS (%) | TPMS (ms) | Characteristics | |
---|---|---|---|---|
Type 1 (T1) | <6 | ≥6 | Before AVC | Normal segmental activation ( |
Type 2 (T2) | <6 | ≥6 | After AVC | Post systolic deformation ( |
Type 3 (T3) | ≥6 | ≥6 | Before AVC | ISL followed by normal segmental activation ( |
Type 4 (T4) | ≥6 | ≥6 | After AVC | ISL followed by post systolic deformation ( |
Type 5 (T5) | <6 | ≥6 | First third of systole | Early systolic shortening followed by no active event during systole ( |
Type 6 (T6) | <6 | <6 | - | No active event during systole ( |
Type 7 (T7) | ≥6 | <6 | - | Holo-systolic lengthening ( |
Unit | Control group (n=100) | Ischemic group (n=50) | |
---|---|---|---|
Age | (years) | 45±14 | 54±16 |
SBP | (mmHg) | 118±14 | 118±18 |
DBP | (mmHg) | 71±9 | 72±9 |
HR | (bpm) | 66±13 | 67±14 |
IVSd | (mm) | 8.6±1.7 | 10.2±3.2 |
PWd | (mm) | 8.7±1.4 | 9.2±2.2 |
LVIDd | (mm) | 47.4±4.8 | 57.0±8.5 |
LVIDs | (mm) | 30.8 ±5.3 | 43.3 ±12.7 |
LVMi | (g/m2) | 78.5±22.3 | 116.7±39.7 |
LV EDVi | (ml/ m2) | 56±13 | 79±29 |
LV ESVi | (ml/ m2) | 21±7 | 44±26 |
LV EF | (%) | 64±6 | 48±14 |
LAESVi | (ml/ m2) | 33±8 | 43±16 |
E wave | (m/s) | 72±15 | 72±19 |
DTE | (ms) | 185±38 | 203±54 |
A wave | (m/s) | 46±13 | 60±28 |
E/A | 1.7±0.5 | 1.5±1.0 | |
LV s’ | (cm/s) | 10±2 | 7±3 |
LV e’ | (cm/s) | 13±3 | 8±4 |
LV a’ | (cm/s) | 10±3 | 7±3 |
E/e’ | 6±1 | 11±6 |
|
TAPSE | (mm) | 23±3 | 16±3 |
LSC | Control group (n=100) | Ischemic group (n=50) | ||
---|---|---|---|---|
PSS | PMS | PSS | PMS | |
Type 1 | -22.4±4.0 |
-22.6±4.0 |
-19.0±5.8 | -19.2±5.8 |
Type 2 | -20.2±4.2 |
-21.8±4.4 |
-12.2±6.0 | -14.9±5.8 |
Type 3 | - | - | -12.3±2.4 | -12.4±2.3 |
Type 4 | -21.7±1.7 |
-23.8±1.3 |
-9.4±4.8 | -13.9±5.3 |
Type 5 | - | - | -8.1±2.1 | -9.1±1.9 |
Type 6 | - | - | -2.9±1.5 | -3.8±1.5 |
Type 7 | - | - | -2.3±1.1 | -3.0±1.2 |